Ziltivekimab

• CAT Number: I042140
• CAS Number: 2226654-05-1
• Purity: ≥95%

Ziltivekimab（Cat No.:I042140）is an investigational monoclonal antibody that targets IL-6R (interleukin-6 receptor), a key receptor involved in the inflammatory response. IL-6 is a cytokine that plays a central role in the pathogenesis of several autoimmune and inflammatory diseases, including rheumatoid arthritis, juvenile idiopathic arthritis, and chronic inflammatory conditions. By inhibiting IL-6R, ziltivekimab aims to reduce inflammation and alleviate symptoms associated with these diseases. It is being studied in clinical trials to assess its safety and efficacy in treating various chronic inflammatory conditions, with the goal of improving patient outcomes.